These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study. Lam AR; Teplow DB; Stanley HE; Urbanc B J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400 [TBL] [Abstract][Full Text] [Related]
3. Nanoprobing of misfolding and interactions of amyloid β 42 protein. Kim BH; Lyubchenko YL Nanomedicine; 2014 May; 10(4):871-8. PubMed ID: 24333588 [TBL] [Abstract][Full Text] [Related]
4. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms. Coskuner O; Wise-Scira O; Perry G; Kitahara T ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682 [TBL] [Abstract][Full Text] [Related]
5. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides. Wang L; Eom K; Kwon T Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350 [TBL] [Abstract][Full Text] [Related]
6. In silico study of amyloid beta-protein folding and oligomerization. Urbanc B; Cruz L; Yun S; Buldyrev SV; Bitan G; Teplow DB; Stanley HE Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17345-50. PubMed ID: 15583128 [TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease. Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403 [TBL] [Abstract][Full Text] [Related]
8. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds. Dong M; Zhao W; Hu D; Ai H; Kang B ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement. Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202 [TBL] [Abstract][Full Text] [Related]
10. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway. Chang YJ; Chen YR FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730 [TBL] [Abstract][Full Text] [Related]
11. Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide. Lv Z; Condron MM; Teplow DB; Lyubchenko YL J Neuroimmune Pharmacol; 2013 Mar; 8(1):262-73. PubMed ID: 23143330 [TBL] [Abstract][Full Text] [Related]
19. Characterizing the structural and thermodynamic properties of Aβ42 and Aβ40. Lin Y; Im H; Diem LT; Ham S Biochem Biophys Res Commun; 2019 Mar; 510(3):442-448. PubMed ID: 30722990 [TBL] [Abstract][Full Text] [Related]
20. Early Divergence in Misfolding Pathways of Amyloid-Beta Peptides. Mamone S; Glöggler S; Becker S; Rezaei-Ghaleh N Chemphyschem; 2021 Nov; 22(21):2158-2163. PubMed ID: 34355840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]